Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      4 trials found for Transthyretin amyloid cardiomyopathy, Transthyretin amyloidosis cardiomyopathy

      Recruiting
      Not yet recruiting
      Recruiting
      NCT06321523
      A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

      Transthyretin Amyloid Cardiomyopathy

      Male or Female
      19+ years
      3study location(s)
      Recruiting
      NCT06086353
      A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India

      Transthyretin Amyloid Cardiomyopathy

      Male or Female
      18+ years
      3study location(s)
      Recruiting
      NCT06651073
      ATTR-CM: A Multi-country, Non-interventional Disease Registry

      Transthyretin Amyloid Cardiopathy

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT04801329
      Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

      ATTR-CM (Transthyretin Amyloid Cardiomyopathy)

      Male or Female
      19+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.